CA2063511C - Method for producing human serum albumin - Google Patents

Method for producing human serum albumin Download PDF

Info

Publication number
CA2063511C
CA2063511C CA002063511A CA2063511A CA2063511C CA 2063511 C CA2063511 C CA 2063511C CA 002063511 A CA002063511 A CA 002063511A CA 2063511 A CA2063511 A CA 2063511A CA 2063511 C CA2063511 C CA 2063511C
Authority
CA
Canada
Prior art keywords
acid
serum albumin
human serum
medium
hsa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002063511A
Other languages
English (en)
French (fr)
Other versions
CA2063511A1 (en
Inventor
Kaoru Kobayashi
Shinobu Kuwae
Tomoshi Ooya
Hirotoshi Fukutsuka
Akinori Sumi
Wataru Ohtani
Takao Ohmura
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of CA2063511A1 publication Critical patent/CA2063511A1/en
Application granted granted Critical
Publication of CA2063511C publication Critical patent/CA2063511C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA002063511A 1991-03-20 1992-03-19 Method for producing human serum albumin Expired - Lifetime CA2063511C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3081719A JPH0671432B2 (ja) 1991-03-20 1991-03-20 ヒト血清アルブミンの製造方法
JP81719/1991 1991-03-20

Publications (2)

Publication Number Publication Date
CA2063511A1 CA2063511A1 (en) 1992-09-21
CA2063511C true CA2063511C (en) 2001-11-27

Family

ID=13754223

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002063511A Expired - Lifetime CA2063511C (en) 1991-03-20 1992-03-19 Method for producing human serum albumin

Country Status (9)

Country Link
US (1) US5334512A (OSRAM)
EP (1) EP0504823B1 (OSRAM)
JP (1) JPH0671432B2 (OSRAM)
KR (1) KR100218853B1 (OSRAM)
CA (1) CA2063511C (OSRAM)
DE (1) DE69220113T2 (OSRAM)
DK (1) DK0504823T3 (OSRAM)
ES (1) ES2102420T3 (OSRAM)
TW (1) TW198683B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
CA2136564C (en) * 1993-11-26 2008-04-08 Kaoru Kobayashi Process for producing human serum albumin
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
PL335975A1 (en) 1997-04-03 2000-06-05 Yoshitomi Pharmaceutical Method of obtaining a heterologous protein
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
US8263401B2 (en) * 2004-05-26 2012-09-11 University Of Medicine And Dentistry Of New Jersey Adenylyl cyclase antibodies, compositions and uses thereof
WO2006066595A2 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
NZ602479A (en) 2008-05-15 2013-05-31 R Tech Ueno Ltd Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
CA3047523A1 (en) * 2016-12-21 2018-06-28 Prometic Biosciences Inc. Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US12151045B2 (en) 2020-12-28 2024-11-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
KR20240032272A (ko) 2022-09-02 2024-03-12 조신아 아동원예지도사 교육방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (en) * 1981-11-12 1984-08-08 The Upjohn Company Albumin-based nucleotides, their replication and use, and plasmids for use therein
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
EP0206733A1 (en) * 1985-06-17 1986-12-30 Genex Corporation Cloned human serum albumin gene
DK13087A (da) * 1986-01-13 1987-07-14 Genex Corp Gensekvens til fremstilling af human serumalbumin i bacillus
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
JPS6460370A (en) * 1987-05-27 1989-03-07 Sankyo Co High-temperature culture of yeast
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えｄｎａ、形質転換体
JPH01240191A (ja) * 1988-02-16 1989-09-25 Green Cross Corp:The 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
GB8820951D0 (en) * 1988-09-07 1988-10-05 Delta Biotechnology Ltd Fermentation method
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
JP2855130B2 (ja) * 1989-07-19 1999-02-10 吉富製薬株式会社 異種蛋白発現用融合酵母菌、該菌の製造方法および異種蛋白の製造方法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法

Also Published As

Publication number Publication date
DE69220113D1 (de) 1997-07-10
ES2102420T3 (es) 1997-08-01
EP0504823A3 (en) 1993-04-07
EP0504823A2 (en) 1992-09-23
DE69220113T2 (de) 1997-09-25
TW198683B (OSRAM) 1993-01-21
KR100218853B1 (ko) 1999-10-01
CA2063511A1 (en) 1992-09-21
JPH04293495A (ja) 1992-10-19
US5334512A (en) 1994-08-02
EP0504823B1 (en) 1997-06-04
KR920018218A (ko) 1992-10-21
JPH0671432B2 (ja) 1994-09-14
DK0504823T3 (da) 1997-06-23

Similar Documents

Publication Publication Date Title
CA2063511C (en) Method for producing human serum albumin
EP0156355B2 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
US5294699A (en) Inhibition of coloration of human serum albumin
US5612197A (en) Process for producing recombinant human serum albumin
US5369020A (en) Method for suppressing coloring of human serum albumin
CA2136564C (en) Process for producing human serum albumin
JP3661191B2 (ja) タンパク質の生産方法
CA2165666A1 (en) Culture medium for recombinant yeasts
US5866371A (en) Process for using the yeast ADH II promoter system for the production of heterologous proteins in high yields
HU191129B (en) Process for production of riboflavin
US6309864B1 (en) Process for producing foreign proteins
EP0146929A2 (en) Microorganism of the genus Serratia containing a hybrid plasmid and process for preparing the same
EP0233937B1 (en) Fermentation methods for hepatitis vaccine production
JP3837775B2 (ja) ヒト血清アルブミンの分解抑制方法
JP3772355B2 (ja) ヒト血清アルブミンの製造方法
KR930001387B1 (ko) 유전자 재조합에 의한 인간 알파인터페론의 제조방법
EP0646645B1 (en) A process for producing a substance
JP2005312463A (ja) ヒト血清アルブミンの製造方法
JPH1014564A (ja) 蛋白質の製造方法
EP0213029A2 (en) Increased fermentation yield of expressed protein

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry